{"doi":"10.1093/infdis/jiad535","title":"Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)","abstract":"BACKGROUND: Despite highly effective HIV preexposure prophylaxis (PrEP) options, no options provide on-demand, nonsystemic, behaviorally congruent PrEP that many desire. A tenofovir-medicated rectal douche before receptive anal intercourse may provide this option. METHODS: Three tenofovir rectal douches-220 mg iso-osmolar product A, 660 mg iso-osmolar product B, and 660 mg hypo-osmolar product C-were studied in 21 HIV-negative men who have sex with men. We sampled blood and colorectal tissue to assess safety, acceptability, pharmacokinetics, and pharmacodynamics. RESULTS: The douches had high acceptability without toxicity. Median plasma tenofovir peak concentrations for all products were several-fold below trough concentrations associated with oral tenofovir disoproxil fumarate (TDF). Median colon tissue mucosal mononuclear cell (MMC) tenofovir-diphosphate concentrations exceeded target concentrations from 1 hour through 3 to 7 days after dosing. For 6-7 days after a single product C dose, MMC tenofovir-diphosphate exceeded concentrations expected with steady-state oral TDF 300 mg on-demand 2-1-1 dosing. Compared to predrug baseline, HIV replication after ex vivo colon tissue HIV challenge demonstrated a concentration-response relationship with 1.9 log10 maximal effect. CONCLUSIONS: All 3 tenofovir douches achieved tissue tenofovir-diphosphate concentrations and colorectal antiviral effect exceeding oral TDF and with lower systemic tenofovir. Tenofovir douches may provide a single-dose, on-demand, behaviorally congruent PrEP option, and warrant continued development. Clinical Trials Registration . NCT02750540.","journal":"The Journal of Infectious Diseases","year":2023,"id":339031,"datarank":0.5418877973827679,"base_score":2.8903717578961645,"endowment":2.8903717578961645,"self_citation_contribution":0.4335557636844247,"citation_network_contribution":0.10833203369834325,"self_endowment_contribution":0.4335557636844247,"citer_contribution":0.10833203369834325,"corpus_percentile":null,"corpus_rank":null,"citation_count":17,"citer_count":10,"citers_with_citation_signal":5,"citers_with_endowment":5,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9515,"is_data_producer":true,"deposit_databanks":{"ClinicalTrials.gov":["NCT02750540"]},"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":495815,"name":"Ian McGowan","orcid":"0000-0002-6470-8476","position":1,"is_corresponding":false},{"id":510121,"name":"Peter A. Anton","orcid":"0000-0002-4677-6782","position":2,"is_corresponding":false},{"id":412457,"name":"Edward J. Fuchs","orcid":null,"position":3,"is_corresponding":false},{"id":644588,"name":"Ken Ho","orcid":"0000-0001-7973-1268","position":4,"is_corresponding":false},{"id":408971,"name":"Alex Carballo‐Diéguez","orcid":"0000-0001-5888-031X","position":5,"is_corresponding":false},{"id":924069,"name":"Lisa C. Rohan","orcid":"0000-0003-1602-0172","position":6,"is_corresponding":false},{"id":408964,"name":"Rebecca Giguere","orcid":"0000-0002-6529-0550","position":7,"is_corresponding":false},{"id":446538,"name":"Rhonda M. Brand","orcid":null,"position":8,"is_corresponding":false},{"id":1072593,"name":"Stacey Edick","orcid":null,"position":9,"is_corresponding":false},{"id":599996,"name":"Rahul P. Bakshi","orcid":"0000-0003-1478-1031","position":10,"is_corresponding":false},{"id":598004,"name":"Teresa L. Parsons","orcid":null,"position":11,"is_corresponding":false},{"id":1072594,"name":"Madhuri Manohar","orcid":null,"position":12,"is_corresponding":false},{"id":1072595,"name":"Aaron Seigel","orcid":null,"position":13,"is_corresponding":false},{"id":1072596,"name":"Jared Engstrom","orcid":null,"position":14,"is_corresponding":false},{"id":534330,"name":"Julie Elliott","orcid":null,"position":15,"is_corresponding":false},{"id":634592,"name":"Cindy Jacobson","orcid":"0000-0001-9638-7665","position":16,"is_corresponding":false},{"id":1072597,"name":"Christina Bagia","orcid":null,"position":17,"is_corresponding":false},{"id":568387,"name":"Lin Wang","orcid":"0000-0001-5171-2663","position":18,"is_corresponding":false},{"id":1072598,"name":"Amer Al‐khouja","orcid":null,"position":19,"is_corresponding":false},{"id":459082,"name":"Douglas J. Hartman","orcid":"0000-0001-8962-8993","position":20,"is_corresponding":false},{"id":445610,"name":"Namandjé N. Bumpus","orcid":"0000-0002-6096-3824","position":21,"is_corresponding":false},{"id":314442,"name":"Hans Spiegel","orcid":"0000-0001-9552-789X","position":22,"is_corresponding":false},{"id":279020,"name":"Mark A. Marzinke","orcid":"0000-0003-1670-8786","position":23,"is_corresponding":false},{"id":366533,"name":"Craig W. Hendrix","orcid":"0000-0002-5696-8665","position":24,"is_corresponding":false},{"id":776013,"name":"Ethel D. Weld","orcid":"0000-0002-9519-3348","position":0,"is_corresponding":true}],"reference_count":46,"raw_metadata":null,"created_at":"2026-07-19T01:10:40.496978Z","pmid":"38019657","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}